Developing Consensus-Based Outcome Domains for Trials in Children and Adolescents With CKD: An International Delphi Survey.

Chronic kidney disease (CKD) Delphi survey adolescents blood pressure caregivers children clinical trial design consensus core outcome set kidney function life participation mortality outcome measures outcomes patient-centered outcomes pediatrics priority ranking treatment goals

Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
10 2020
Historique:
received: 21 11 2019
accepted: 08 03 2020
pubmed: 14 7 2020
medline: 26 11 2020
entrez: 14 7 2020
Statut: ppublish

Résumé

The inconsistency in outcomes reported and lack of patient-reported outcomes across trials in children with chronic kidney disease (CKD) limits shared decision making. As part of the Standardized Outcomes in Nephrology (SONG)-Kids initiative, we aimed to generate a consensus-based prioritized list of critically important outcomes to be reported in all trials in children with CKD. An online 2-round Delphi survey in English, French, and Hindi languages. Patients (aged 8-21 years), caregivers/family, and health care professionals (HCPs) rated the importance of outcomes using a 9-point Likert scale (7-9 indicating critical importance) and completed a Best-Worst Scale. We assessed the absolute and relative importance of outcomes. Comments were analyzed thematically. 557 participants (72 [13%] patients, 132 [24%] caregivers, and 353 [63%] HCPs) from 48 countries completed round 1 and 312 (56%) participants (28 [40%] patients, 64 [46%] caregivers, and 220 [56%] HCPs) completed round 2. Five outcomes were common in the top 10 for each group: mortality, kidney function, life participation, blood pressure, and infection. Caregivers and HCPs rated cardiovascular disease higher than patients. Patients gave lower ratings to all outcomes compared with caregivers/HCPs except they rated life participation (round 2 mean difference, 0.1), academic performance (0.1), mobility (0.4), and ability to travel (0.4) higher than caregivers and rated ability to travel (0.4) higher than HCPs. We identified 3 themes: alleviating disease and treatment burden, focusing on the whole child, and resolving fluctuating and conflicting goals. Most participants completed the survey in English. Mortality, life participation, kidney function, and blood pressure were consistently highly prioritized by patients, caregivers, and HCPs. Patients gave higher priority to some lifestyle-related outcomes compared with caregivers/HCPs. Establishing critically important outcomes for all trials in children with CKD may improve consistent reporting of survival, kidney health, and clinical and life impact outcomes that are meaningful for decision making.

Identifiants

pubmed: 32654889
pii: S0272-6386(20)30688-0
doi: 10.1053/j.ajkd.2020.03.014
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

533-545

Informations de copyright

Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Charlotte Logeman (C)

Sydney School of Public Health, The University of Sydney, NSW, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Chandana Guha (C)

Sydney School of Public Health, The University of Sydney, NSW, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Martin Howell (M)

Sydney School of Public Health, The University of Sydney, NSW, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Camilla S Hanson (CS)

Sydney School of Public Health, The University of Sydney, NSW, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Jonathan C Craig (JC)

College of Medicine and Public Health, Flinders University, Adelaide, Australia.

Susan Samuel (S)

Department of Pediatrics, Section of Nephrology, University of Calgary, Calgary, AB, Canada.

Michael Zappitelli (M)

Department of Pediatrics, Division of Nephrology, Toronto Hospital for Sick Children, Toronto, Canada.

Mina Matsuda-Abedini (M)

Department of Pediatrics, Division of Nephrology, Toronto Hospital for Sick Children, Toronto, Canada.

Allison Dart (A)

Department of Pediatrics and Child Health, The Children's Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, MB, Canada.

Susan Furth (S)

Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA; Department of Epidemiology, Perelman School of Medicine, Philadelphia, PA; Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, PA.

Allison Eddy (A)

Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.

Jaap Groothoff (J)

Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam University Medical Center, location AMC, Amsterdam, the Netherlands.

Hui-Kim Yap (HK)

Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Detlef Bockenhauer (D)

UCL Department of Renal Medicine and Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.

Aditi Sinha (A)

Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Stephen I Alexander (SI)

Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Stuart L Goldstein (SL)

Center for Acute Care Nephrology, Cincinnati Children's Hospital, Cincinnati, OH.

Debbie S Gipson (DS)

Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI.

Mini Michael (M)

Renal Section, Department of Pediatrics, Baylor College of Medicine/Texas Children's Hospital, Houston, TX.

Amanda Walker (A)

Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia; Department of Nephrology and Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.

Joshua Kausman (J)

Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia; Department of Nephrology and Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.

Segolene Gaillard (S)

Hospices Civils de Lyon, EPICIME-CIC 1407 de Lyon, Inserm, Service de Pharmacologie Clinique, Bron, France.

Justine Bacchetta (J)

Department of Pediatric Nephrology, Reference Center for Rare Renal Diseases, Hospices civils de Lyon, Lyon, France.

Michelle N Rheault (MN)

Division of Nephrology, Department of Pediatrics, University of Minnesota Masonic Children's Hospital, Minneapolis, MN.

Bradley A Warady (BA)

Children's Mercy Hospital, Kansas City, MO.

Alicia Neu (A)

Division of Pediatric Nephrology, The Johns Hopkins University School of Medicine, Baltimore, MD.

Martin Christian (M)

Nottingham Children's Hospital, Nottingham, United Kingdom.

Steven McTaggart (S)

Child and Adolescent Renal Service, Queensland Children's Hospital and University of Queensland, Brisbane, Australia.

Isaac Liu (I)

Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore.

Sharon Teo (S)

Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore.

Benedicte Sautenet (B)

Department of Nephrology Hypertension, dialysis, kidney transplantation, Tours Hospital, SPHERE - INSERM 1246, University of Tours and Nantes, Tours, France.

Talia Gutman (T)

Sydney School of Public Health, The University of Sydney, NSW, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Simon Carter (S)

Sydney School of Public Health, The University of Sydney, NSW, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Armando Teixeira-Pinto (A)

Sydney School of Public Health, The University of Sydney, NSW, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Allison Tong (A)

Sydney School of Public Health, The University of Sydney, NSW, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia. Electronic address: allison.tong@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH